CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE in adult drug associated with AE in senior used to treat disease Lipoxygenase Inhibitors [MoA] Glucocorticoid Receptor Agonists [MoA] Adrenal Insufficiency [Disease/Finding] Adrenal Hyperplasia, Congenital [Disease/Finding] Colitis, Ulcerative [Disease/Finding] Dermatomycoses [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Facial Dermatoses [Disease/Finding] Foot Dermatoses [Disease/Finding] Hand Dermatoses [Disease/Finding] Hemorrhoids [Disease/Finding] Inflammation [Disease/Finding] Leg Dermatoses [Disease/Finding] Pruritus Ani [Disease/Finding] Rheumatic Diseases [Disease/Finding] Scalp Dermatoses [Disease/Finding] Shock [Disease/Finding] Skin Diseases, Parasitic [Disease/Finding] Status Asthmaticus [Disease/Finding] Tuberculosis, Cutaneous [Disease/Finding] Skin Diseases, Viral [Disease/Finding] Skin Diseases, Eczematous [Disease/Finding] Hydrocortisone [Chemical/Ingredient] Carbohydrate Metabolism Alteration [PE] Decreased Glucocorticoid Secretion [PE] Decreased Leukotriene Activity [PE] Decreased Lysosomal Function [PE] Decreased Prostaglandin Activity [PE] Decreased Protein Synthesis [PE] Decreased Thromboxane Activity [PE] Lipid Metabolism Alteration [PE] Decreased Polymorphonuclear Leukocyte Migration [PE] Decreased Fibroblast Migration [PE] Decreased Capillary Permeability [PE] H [Preparations] HYDROCORTISONE https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/008697s032_33lbl.pdf Hydrocortisone HYDROCORTISONE C0020268 <VANDF_Record>50.6^286^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>286</VA_IEN> WI4X0X7BPJ Active Ingredient 4017941 N0000146291 C15494 <VANDF_Record>50.416^536^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>536</VA_IEN> 5492 endocrine system disease muscular weakness AE duodenal ulcer AE